Insights

Loading spinner
Gathering insights about Trillium Therapeutics Inc.

Trillium Therapeutics Inc. Tech Stack

Trillium Therapeutics Inc. uses 8 technology products and services including Twemoji, Font Awesome, jQuery, and more. Explore Trillium Therapeutics Inc.'s tech stack below.

  • Twemoji
    Font Scripts
  • Font Awesome
    Font Scripts
  • jQuery
    Javascript Libraries
  • jQuery UI
    Javascript Libraries
  • DocuSign
    Miscellaneous
  • PHP
    Programming Languages
  • Google Tag Manager
    Tag Management
  • Google Analytics
    Web Analytics

Media & News

Trillium Therapeutics Inc.'s Email Address Formats

Trillium Therapeutics Inc. uses at least 1 format(s):
Trillium Therapeutics Inc. Email FormatsExamplePercentage
First@trilliumtherapeutics.comJohn@trilliumtherapeutics.com
38%
Last@trilliumtherapeutics.comDoe@trilliumtherapeutics.com
12%
First@trilliumtherapeutics.comJohn@trilliumtherapeutics.com
38%
Last@trilliumtherapeutics.comDoe@trilliumtherapeutics.com
12%

Frequently Asked Questions

What is Trillium Therapeutics Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Trillium Therapeutics Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Trillium Therapeutics Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Trillium Therapeutics Inc.'s official website is trilliumtherapeutics.com and has social profiles on LinkedInCrunchbase.

How much revenue does Trillium Therapeutics Inc. generate?

Minus sign iconPlus sign icon
As of December 2025, Trillium Therapeutics Inc.'s annual revenue is estimated to be $4M.

What is Trillium Therapeutics Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Trillium Therapeutics Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Trillium Therapeutics Inc. have currently?

Minus sign iconPlus sign icon
As of December 2025, Trillium Therapeutics Inc. has approximately 13 employees across 1 continents, including North America. Key team members include Senior Vice President, Head Of Clinical Operations: K. L.Associate Director Of Clinical Operations: A. M.Director, Drug Development: C. B.. Explore Trillium Therapeutics Inc.'s employee directory with LeadIQ.

What industry does Trillium Therapeutics Inc. belong to?

Minus sign iconPlus sign icon
Trillium Therapeutics Inc. operates in the Biotechnology Research industry.

What technology does Trillium Therapeutics Inc. use?

Minus sign iconPlus sign icon
Trillium Therapeutics Inc.'s tech stack includes TwemojiFont AwesomejQueryjQuery UIDocuSignPHPGoogle Tag ManagerGoogle Analytics.

What is Trillium Therapeutics Inc.'s email format?

Minus sign iconPlus sign icon
Trillium Therapeutics Inc.'s email format typically follows the pattern of First@trilliumtherapeutics.com. Find more Trillium Therapeutics Inc. email formats with LeadIQ.

How much funding has Trillium Therapeutics Inc. raised to date?

Minus sign iconPlus sign icon
As of December 2025, Trillium Therapeutics Inc. has raised $130M in funding. The last funding round occurred on Sep 10, 2020 for $130M.

Trillium Therapeutics Inc.

Biotechnology ResearchMassachusetts, United States11-50 Employees

Trillium Therapeutics Inc. (NASDAQ/TSX:TRIL) is a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer. We have a strong focus on CD47, a molecule that tumors frequently use to evade the immune system. CD47 is a protective “do not eat” signal that blocks the ability of certain immune cells to destroy the tumor. By blocking this “do not eat” signal with decoy receptors, we aim to unmask tumor cells and make them visible to, and eradicated by, the immune system.

Section iconCompany Overview

Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconFunding & Financials

  • $130M

    Trillium Therapeutics Inc. has raised a total of $130M of funding over 9 rounds. Their latest funding round was raised on Sep 10, 2020 in the amount of $130M.

  • $1M$10M

    Trillium Therapeutics Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $130M

    Trillium Therapeutics Inc. has raised a total of $130M of funding over 9 rounds. Their latest funding round was raised on Sep 10, 2020 in the amount of $130M.

  • $1M$10M

    Trillium Therapeutics Inc.'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.